epidem
sever
acut
respiratori
syndrom
sar
caught
medic
profess
surpris
accumul
global
total
number
case
death
casefat
ratio
although
novel
coronaviru
sarscov
discov
within
week
treatment
inevit
empir
control
clinic
trial
possibl
epidem
new
seriou
ill
mani
antivir
immunomodulatori
drug
well
treatment
convalesc
patient
plasma
tradit
chines
medicin
tri
ribavirin
corticosteroid
far
wide
use
treatment
sar
later
phase
epidem
lopinavir
ritonavir
combin
also
use
hong
kong
ribavirin
use
extens
treatment
sar
given
patient
hong
kong
nucleosid
analogu
activ
number
dna
rna
virus
vitro
mechan
action
ribavirin
studi
decad
still
activ
debat
earli
march
isol
sarscov
mani
expert
believ
mysteri
sever
ill
due
unknown
viru
ribavirin
empir
given
broad
spectrum
antivir
activ
furthermor
corticosteroid
increasingli
prescrib
treatment
sar
believ
treatment
would
danger
cover
antivir
agent
publish
report
effect
ribavirin
mostli
retrospect
case
seri
intrins
methodolog
issu
difficult
draw
conclus
major
side
effect
ribavirin
anaemia
occur
patient
anaemia
reduc
oxygen
transport
potenti
exist
problem
oxygen
tissu
hypoxia
signific
side
effect
includ
rais
transaminas
bradycardia
well
hypocalcaemia
hypomagnesaemia
risk
teratogen
detail
studi
clinic
cours
viral
load
peiri
et
al
report
patient
given
standard
regimen
ribavirin
steroid
show
peak
viral
load
day
onset
ill
studi
although
involv
small
number
subject
clearli
indic
inabl
ribavirin
clear
sarscov
patient
sar
result
studi
also
explain
patient
treat
ribavirin
earli
ill
abl
infect
healthcar
worker
subsequ
requir
endotrach
intub
lack
vitro
activ
drug
sarscov
cast
doubt
use
ribavirin
sar
use
ribavirin
sar
review
elsewher
lopinavir
ritonavir
lopinavir
ritonavir
lpvr
proteas
inhibitor
combin
licens
treatment
hiv
diseas
ritonavir
littl
antivir
activ
role
inhibit
mediat
metabol
lopinavir
thu
increas
serum
concentr
lopinavir
laboratori
lopinavir
ribavirin
signific
synerg
inhibit
sarscov
basi
combinationtogeth
steroidshav
use
centr
hong
kong
sinc
mid
april
retrospect
studi
author
found
patient
receiv
earli
treatment
lpvr
togeth
ribavirin
steroid
significantli
fewer
day
advers
clinic
outcom
acut
respiratori
distress
syndrom
death
histor
control
receiv
ribavirin
steroid
benefit
lpvr
group
includ
favour
viral
load
profil
six
patient
earli
rise
lymphocyt
count
reduc
need
rescu
puls
steroid
dose
advers
event
attribut
lpvr
minim
similar
find
report
case
control
studi
involv
patient
hong
kong
randomis
control
trial
plan
hong
kong
confirm
result
sar
reemerg
corticosteroid
use
wide
treat
sar
first
mainland
china
hong
kong
main
rational
use
sar
acut
viral
respiratori
infect
earli
respons
cytokin
interferon
gamma
ifnc
tumour
necrosi
factor
interleukin
interleukin
contribut
tissu
injuri
corticosteroid
treatment
may
suppress
cytokin
storm
peiri
et
al
hypothesis
clinic
worsen
often
observ
second
phase
ill
result
immunopatholog
damag
overexuber
host
respons
newli
publish
report
wong
et
al
show
consecut
adult
sar
mark
increas
cytokin
ifnc
inflammatori
cytokin
least
week
diseas
onset
chemokin
profil
show
signific
increas
monocyt
chemoatttract
ifnc
induc
corticosteroid
significantli
reduc
concentr
day
treatment
data
confirm
cell
mediat
immun
hyperinn
inflammatori
respons
sar
accumul
monocytesmacrophag
neutrophil
anoth
rational
use
steroid
sar
necroscop
find
featur
acut
respiratori
distress
syndrom
ard
report
success
use
steroid
treatment
ard
septic
shock
addit
system
steroid
use
treatment
infect
variabl
success
hand
potenti
corticosteroid
suppress
innat
host
defenc
sarscov
result
increas
viral
replic
consid
chu
et
al
report
increas
viral
load
one
patient
follow
puls
methylprednisolon
therapi
increas
replic
respiratori
virus
also
report
follow
steroid
therapi
wherea
low
dose
steroid
mgkgday
prednisolon
equival
use
infect
ard
septic
shock
puls
dose
gday
methylprednisolon
gener
recommend
condit
use
extens
sar
particularli
second
week
ill
patient
often
show
acut
clinic
deterior
efficaci
puls
steroid
sar
remain
determin
conceiv
higher
steroid
dose
result
higher
incid
sever
side
effect
publish
case
seri
examin
clinic
efficaci
steroid
treatment
sar
suffer
methodolog
problem
ribavirin
addit
wide
varieti
steroid
dose
schedul
make
retrospect
analysi
steroid
efficaci
except
difficult
far
systemat
review
efficaci
corticosteroid
treatment
sar
base
numer
publish
studi
investig
feel
judici
use
corticosteroid
benefici
randomis
control
studi
need
confirm
benefici
effect
well
give
insight
optim
regimen
possibl
benefici
effect
howev
balanc
signific
side
effect
includ
nosocomi
infect
hyperglycaemia
hypokalaemia
hypertens
gastrointestin
haemorrhag
avascular
necrosi
bone
avn
perhap
distress
medium
term
side
effect
steroid
patient
sar
preliminari
data
cohort
adult
patient
princess
margaret
hospit
hong
kong
receiv
variou
dose
steroid
magnet
reson
imag
perform
averag
month
ill
onset
show
avn
present
unpublish
data
unilater
involv
femor
head
bilater
involv
femor
head
univari
analysi
show
total
steroid
dose
significantli
associ
develop
avn
unpublish
data
sar
recent
appear
limit
number
patient
manag
differ
locat
understand
lack
systemat
critic
evalu
treatment
form
randomis
control
trial
nonetheless
enorm
effort
research
put
look
effect
treatment
sar
highli
commend
recent
reemerg
sar
result
secondari
spread
nevertheless
remind
could
strike
may
even
threaten
deadli
avian
influenza
repeatedli
demonstr
abil
infect
human
may
acquir
abil
effici
human
human
transmiss
futur
hope
epidem
new
diseas
strike
systemat
way
evalu
treatment
modal
would
place
provid
answer
import
question
shortest
possibl
time
